Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/21/2012 | CN102784125A Cefetamet pivoxil composition freeze-dried orally disintegrating tablet and preparation method thereof |
11/21/2012 | CN102784124A Cefuroxime axetil composition freeze-dried orally disintegrating tablets and preparation method thereof |
11/21/2012 | CN102784122A Isoniazid composition freeze-dried orally disintegrating tablet and preparation method thereof |
11/21/2012 | CN102784121A Levofloxacin composition freeze-dried orally disintegrating tablets and preparation method thereof |
11/21/2012 | CN102784120A Metronidazole composition freeze-dried disintegrating tablets for vaginas and preparation method thereof |
11/21/2012 | CN102784119A Roxithromycin composition freeze-dried orally disintegrating tablets and preparation method thereof |
11/21/2012 | CN102784118A Fosfomycin calcium composition freeze-dried orally disintegrating tablets and preparation method thereof |
11/21/2012 | CN102784117A Gentamicin sulfate composition freeze-dried orally disintegrating tablet and preparation method thereof |
11/21/2012 | CN102784108A Ulifloxacin water-soluble salt injection |
11/21/2012 | CN102784104A Erythromycin ethylsuccinate emulsion injection and its preparation method |
11/21/2012 | CN102784100A Medical biocolloid solution for sterilization and preparation method thereof |
11/21/2012 | CN102784095A Glycyrrhetinic acid hydrogel preparation, its preparation method and its application |
11/21/2012 | CN102784072A Footbath liquid |
11/21/2012 | CN102784069A Zinc-loaded calcium phosphate antibacterial material and preparation method thereof |
11/21/2012 | CN102783570A Feed for treatment of duck influenza and preparation method thereof |
11/21/2012 | CN102499922B Cefmenoxime hydrochloride composition for injection and preparation thereof |
11/21/2012 | CN102416166B Aerosol inhalant containing interferon alpha and ipratropium bromide |
11/21/2012 | CN102416024B Phage oral microsphere preparation and preparation method thereof |
11/21/2012 | CN102416014B Application of alkaloid component composition to preparation of medicament for resisting influenza A H1N1 virus |
11/21/2012 | CN102335192B Tinea pedis tincture |
11/21/2012 | CN102327269B Solid lipidosome preparation of compound cefaclor medicinal composition |
11/21/2012 | CN102327217B Solid cefpodoxime proxetil liposome preparation |
11/21/2012 | CN102309451B Nifuratel liposome solid preparation |
11/21/2012 | CN102302575B Oral medicament for treating white scour of piglets and preparation method thereof |
11/21/2012 | CN102283838B Application of ethoxysanguinarine to pharmacy |
11/21/2012 | CN102283800B Sertaconazole nitrate suppository for treating vaginitis and preparation method thereof |
11/21/2012 | CN102268422B Cordyceps sobolifera protease capable of inhibiting human immunodeficiency virus-1 (HIV-1) reverse transcriptase and preparation method for Cordyceps sobolifera protease |
11/21/2012 | CN102268395B Marine Penicillium strain and application thereof |
11/21/2012 | CN102258723B Traditional Chinese medicine composition for treating chronic hepatitis B |
11/21/2012 | CN102258568B Method for preparing external rabdosia rubescens antibacterial cream |
11/21/2012 | CN102258460B Baicalein liposome gel and preparation method thereof |
11/21/2012 | CN102250915B Miichthys miiuy alpha chemokine gene CXCL10 as well as detection method and application thereof |
11/21/2012 | CN102247375B Cefotetan disodium for injection, and preparation method thereof |
11/21/2012 | CN102240346B Chinese medicine oral solution for treating infectious bursal disease of chicken |
11/21/2012 | CN102210860B Mycobacterium tuberculosis TB10.4-F1 fusion protein vaccine and preparation method thereof |
11/21/2012 | CN102210859B Mycobacterium tuberculosis ESAT-6-F2 fusion protein subunit vaccine and preparation method thereof |
11/21/2012 | CN102204916B Pharmaceutical composition containing cefmetazole sodium compound, and preparation method thereof |
11/21/2012 | CN102204915B Pharmaceutical composition containing cefotiam hydrochloride compound and preparation method thereof |
11/21/2012 | CN102198133B Application of 8-difluoro methoxy fluoroquinolone and composition thereof to tuberculosis treatment |
11/21/2012 | CN102174477B Hepatitis A virus strain SH and diploid cell adaptation method thereof |
11/21/2012 | CN102174476B Inactivated vaccine for preventing duck virus hepatitis and preparation method thereof |
11/21/2012 | CN102166350B Flounders quintuplet inactivated vaccine and preparation method thereof |
11/21/2012 | CN102161667B Sulbenicillin sodium and sulbenicillin sodium used for injection |
11/21/2012 | CN102120000B Composition of effective parts of traditional Chinese medicine preparation for resisting Coxsackie virus B and preparation method thereof |
11/21/2012 | CN102078550B Chinese herbal medicine extract preparation for preventing and treating mycoplasma gallisepticum and preparation method thereof |
11/21/2012 | CN102068695B Method for producing quadruple inactivated vaccine for newcastle disease, infectious bronchitis, avian influenza (H9 subtype) and infectious bursal disease |
11/21/2012 | CN102058880B Method for producing trivalent inactivated vaccines for porcine infectious pleuropneumonia |
11/21/2012 | CN102030819B Broad spectrum polypeptin and application thereof |
11/21/2012 | CN102000030B Arbidol dry suspension and preparation method thereof |
11/21/2012 | CN101991845B Duck infectious serositis inactivated vaccine emulsification method |
11/21/2012 | CN101983628B Mezlocillin sodium and sulbactam sodium drug composite microsphere injection |
11/21/2012 | CN101955461B Hsp90 inhibitor Xbj-B11 and preparation method and application thereof |
11/21/2012 | CN101954075B Method for preparing oral avian influenza vaccine from transgenic dunaliella |
11/21/2012 | CN101919930B Drug composition for treating swine influenza and preparation method and application thereof |
11/21/2012 | CN101890037B Nuezhenoside and hyperin composition and application thereof for preparing medicine |
11/21/2012 | CN101845456B Corn expression vector of tubercle Ag85B gene and application thereof |
11/21/2012 | CN101845449B Fusion gene of Hepatitis B virus L gene and tubercle Esat6 and construction and application of expression vector thereof |
11/21/2012 | CN101822701B Poplar flower sustained release tablet for treating livestock and poultry dysentery and enteritis and preparation method thereof |
11/21/2012 | CN101775067B New synthesized antibacterial peptide as well as preparation method and application thereof |
11/21/2012 | CN101773672B Oral biological agent for preventing and curing prawn leukopathia |
11/21/2012 | CN101709058B Polyene macrolides compound, preparation and application thereof |
11/21/2012 | CN101664378B Medical composition of recombinant human serum albumin and interferon alpha fusion protein |
11/21/2012 | CN101633639B High-purity fleroxacin compound |
11/21/2012 | CN101580849B Dna-transfection system for generation of infectious influenza virus |
11/21/2012 | CN101491671B Cross-protection vaccine and building method thereof |
11/21/2012 | CN101487009B Method for preparing vaccine for anti-HPV 16 infection by pichia yeast expression system |
11/21/2012 | CN101484444B Novel pyridazine compound and use thereof |
11/21/2012 | CN101327010B Method for preparing amber ginseng |
11/21/2012 | CN101198374B Antibody or fragment thereof having anti-HIV neutralizing activity |
11/21/2012 | CN101137382B Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
11/20/2012 | US8314262 Inhibitors of yeast filamentous growth and method of their manufacture |
11/20/2012 | US8314217 Cross-linked glycopeptide-cephalosporin antibiotics |
11/20/2012 | US8314090 Methods of synthesis of benzazepine derivatives |
11/20/2012 | US8314089 Substituted pyrazolamides and their use |
11/20/2012 | US8314067 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor |
11/20/2012 | US8313928 Expression system |
11/20/2012 | US8313913 Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa |
11/20/2012 | US8313780 Silver-based inorganic antimicrobial agent, method for preparing the same and antimicrobial product |
11/20/2012 | US8313776 Antibiotic product, use and formulation thereof |
11/20/2012 | US8313775 Antibiotic product, use and formulation thereof |
11/20/2012 | US8313751 Compositions and methods for the prophylaxis or treatment of viral diseases |
11/20/2012 | CA2762042C Chimeric influenza virus-like particles comprising hemagglutinin |
11/20/2012 | CA2692358C Recombinant human interferon-like proteins |
11/20/2012 | CA2596387C 18-membered macrocycles and analogs thereof |
11/20/2012 | CA2549675C Oxazolidinone-quinolone hybrid antibiotics |
11/20/2012 | CA2537559C Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy |
11/20/2012 | CA2493839C Breath freshening and oral cleansing product with magnolia bark extract |
11/20/2012 | CA2475190C Use of rhodococcus for preventing post-weaning multisystemic wasting syndrome |
11/20/2012 | CA2467365C Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions |
11/20/2012 | CA2448796C Vaccine against the nile fever virus |
11/20/2012 | CA2380331C Multiple cytokine-antibody complexes |
11/20/2012 | CA2343653C Recombinant newcastle disease virus rna expression systems and vaccines |
11/20/2012 | CA2335362C Use of a dipeptide for stimulating repair processes |
11/15/2012 | WO2012155053A1 Modified biotin-binding protein, fusion proteins thereof and applications |
11/15/2012 | WO2012154777A1 Hepatitis c virus inhibitors |
11/15/2012 | WO2012154775A1 Combinations of darifenacin and salivary stimulants for the treatment of overactive bladder |
11/15/2012 | WO2012154698A2 Method to improve antiviral activity of nucleotide analogue drugs |
11/15/2012 | WO2012154353A1 Macrocyclic triazine compounds for the treatment of hepatitis c |
11/15/2012 | WO2012154321A1 Compounds and pharmaceutical compositions for the treatment of viral infections |
11/15/2012 | WO2012154311A2 Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing |